Literature DB >> 32879639

Study Protocol - Insight 46 Cardiovascular: A Sub-study of the MRC National Survey of Health and Development.

Sarah Ann Mason1, Lamia Al Saikhan1,2, Siana Jones1, Gemma Bale3, Sarah-Naomi James1,4, Heidi Murray-Smith4, Alicja Rapala1, Suzanne Williams1, Brian Wong1, Marcus Richards1, Nick C Fox4, Rebecca Hardy1, Jonathan M Schott1,4, Nish Chaturvedi1, Alun D Hughes1.   

Abstract

The commonest causes of dementia are Alzheimer's disease and vascular cognitive impairment. Although these conditions have been viewed as distinct entities, there is increasing evidence that neurodegenerative and vascular pathologies interact or overlap to cause cognitive decline, and that at least in some cases individuals at risk of cognitive decline exhibit abnormal cardiovascular physiology long before emergence of disease. However, the mechanisms linking haemodynamic disturbances with cognitive impairment and the various pathologies that cause dementia are poorly understood. A sub-sample of 502 participants from the Medical Research Council National Survey of Health and Development (NSHD) have participated in the first visit of a neuroscience sub-study referred to as Insight 46, where clinical, cognitive, imaging, and lifestyle data have been collected for the purpose of elucidating the pathological changes preceding dementia. This paper outlines the cardiovascular phenotyping performed in the follow-up visit of Insight 46, with the study participants now aged 74. In addition to standard cardiovascular assessments such as blood pressure measurements, echocardiography, and electrocardiography (ECG), functional Near Infrared Spectroscopy (fNIRS) has been included to provide an assessment of cerebrovascular function. A detailed description of the fNIRS protocol along with preliminary results from pilot data is presented. The combination of lifestyle data, brain structure/function, cognitive performance, and cardiovascular health obtained not only from Insight 46, but also from the whole NSHD provides an exciting opportunity to advance our understanding of the cardiovascular mechanisms underlying dementia and cognitive decline, and identify novel targets for intervention.

Entities:  

Keywords:  Dementia; cognitive decline; functional near infrared spectroscopy (fNIRS); vascular cognitive impairment

Year:  2020        PMID: 32879639      PMCID: PMC7116008          DOI: 10.2991/artres.k.200417.001

Source DB:  PubMed          Journal:  Artery Res        ISSN: 1872-9312            Impact factor:   0.597


  48 in total

Review 1.  Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment.

Authors:  Charles DeCarli
Journal:  Lancet Neurol       Date:  2003-01       Impact factor: 44.182

Review 2.  Brain microbleeds and Alzheimer's disease: innocent observation or key player?

Authors:  Charlotte Cordonnier; Wiesje M van der Flier
Journal:  Brain       Date:  2011-01-21       Impact factor: 13.501

3.  Erratum: Publisher's note: False positives and false negatives in functional near-infrared spectroscopy: issues, challenges, and the way forward.

Authors:  Ilias Tachtsidis; Felix Scholkmann
Journal:  Neurophotonics       Date:  2016-03-28       Impact factor: 3.593

4.  A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness.

Authors:  I Wendelhag; Q Liang; T Gustavsson; J Wikstrand
Journal:  Stroke       Date:  1997-11       Impact factor: 7.914

5.  Low cardiac index is associated with incident dementia and Alzheimer disease: the Framingham Heart Study.

Authors:  Angela L Jefferson; Alexa S Beiser; Jayandra J Himali; Sudha Seshadri; Christopher J O'Donnell; Warren J Manning; Philip A Wolf; Rhoda Au; Emelia J Benjamin
Journal:  Circulation       Date:  2015-02-19       Impact factor: 29.690

6.  The physiological origin of task-evoked systemic artefacts in functional near infrared spectroscopy.

Authors:  Evgeniya Kirilina; Alexander Jelzow; Angela Heine; Michael Niessing; Heidrun Wabnitz; Rüdiger Brühl; Bernd Ittermann; Arthur M Jacobs; Ilias Tachtsidis
Journal:  Neuroimage       Date:  2012-03-09       Impact factor: 6.556

7.  Associations Between Left Ventricular Dysfunction and Brain Structure and Function: Findings From the SABRE (Southall and Brent Revisited) Study.

Authors:  Chloe M Park; Emily D Williams; Nish Chaturvedi; Therese Tillin; Robert J Stewart; Marcus Richards; Dean Shibata; Jamil Mayet; Alun D Hughes
Journal:  J Am Heart Assoc       Date:  2017-04-18       Impact factor: 5.501

8.  Assessment of Exercise Capacity and Oxygen Consumption Using a 6 min Stepper Test in Older Adults.

Authors:  Siana Jones; Therese Tillin; Suzanne Williams; Emma Coady; Nishi Chaturvedi; Alun D Hughes
Journal:  Front Physiol       Date:  2017-06-14       Impact factor: 4.566

9.  Study protocol: Insight 46 - a neuroscience sub-study of the MRC National Survey of Health and Development.

Authors:  Christopher A Lane; Thomas D Parker; Dave M Cash; Kirsty Macpherson; Elizabeth Donnachie; Heidi Murray-Smith; Anna Barnes; Suzie Barker; Daniel G Beasley; Jose Bras; David Brown; Ninon Burgos; Michelle Byford; M Jorge Cardoso; Ana Carvalho; Jessica Collins; Enrico De Vita; John C Dickson; Norah Epie; Miklos Espak; Susie M D Henley; Chandrashekar Hoskote; Michael Hutel; Jana Klimova; Ian B Malone; Pawel Markiewicz; Andrew Melbourne; Marc Modat; Anette Schrag; Sachit Shah; Nikhil Sharma; Carole H Sudre; David L Thomas; Andrew Wong; Hui Zhang; John Hardy; Henrik Zetterberg; Sebastien Ourselin; Sebastian J Crutch; Diana Kuh; Marcus Richards; Nick C Fox; Jonathan M Schott
Journal:  BMC Neurol       Date:  2017-04-18       Impact factor: 2.474

10.  The arterial reservoir pressure increases with aging and is the major determinant of the aortic augmentation index.

Authors:  Justin E Davies; John Baksi; Darrel P Francis; Nearchos Hadjiloizou; Zachary I Whinnett; Charlotte H Manisty; Jazmin Aguado-Sierra; Rodney A Foale; Iqbal S Malik; John V Tyberg; Kim H Parker; Jamil Mayet; Alun D Hughes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.